EphemerisX Research · Deep research

Investigations.

Every question in the company investigations: 52 questions, each answered from the FDA's letters and the company's SEC filings. How this research works →

Aldeyra Therapeutics Reproxalap

CorMedix DefenCath (taurolidine and heparin)

Outlook Therapeutics ONS-5010 (bevacizumab-vikg)

Replimune RP1 (vusolimogene oderparepvec)

Verrica Pharmaceuticals VP-102 (cantharidin)

Prepared from public FDA letters and SEC filings: every quoted passage is matched to the original document, and every “not in” statement comes from a search of the whole document, before it is published. Questions, summaries and connecting sentences are EphemerisX’s wording. Not investment advice. How this research works → · Ask the FDA and SEC Ephemeris →